Implementing Genetic Counseling and Testing into your Practice
BioReference, genpath, GeneDx, OPKO
8/27/20, 6:00 PM
America/Chicago UTC -5
Genetic testing for inherited cancer predisposition syndromes is an evolving field, which includes a growing number of causative genes. Determining when and whom to test is becoming clinically important for more patients and their families. GenPath, a division of BioReference Laboratories, Inc. and GeneDx offer unparalleled experience and expertise in the world of genetic testing, as well as access to ancillary services to help with genetic risk assessment and the counseling process. This presentation will explore the genetic testing process and testing options, highlight the benefits of genetic risk assessment and genetic counseling, and review options for genetic counseling services and other ancillary services designed to enhance the patient and provider experience.
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Provide an overview of the genetic testing process for hereditary cancer, Highlight the benefits of and options for genetic counseling, Outline resources available to healthcare providers and patients throughout the genetic counseling and testing process
Laura Andolina, Sonia Nanda